What is Malarone?
It could take just one bite from one infected mosquito to get malaria, a serious and sometimes fatal disease. Infected mosquitoes are not just found in the jungle - they can be almost anywhere: the beach, the resort's pool, even inside your hotel room. MALARONE gives you the protection you need almost anywhere you travel. Before your next trip, talk to your doctor about MALARONE.
Malarone is proven effective
Malarone is 98% effective in preventing infection with Plasmodium falciparum, the parasite species that is responsible for most malaria deaths. It is approved for use, even in areas where chloroquine resistance has been reported. MALARONE has been recommended by the Centers for Disease Control and Prevention (CDC) as an option for the prevention of P. falciparum malaria. MALARONE works by defending your body against infection in both your liver and blood where MALARONE then kills the malaria parasites.
Causes of Malaria
Malaria is spread from the bite of a mosquito. When a mosquito bites an infected person, it ingests the malaria parasites found in that person's blood. After one week or more, the mosquito can spread the parasite to other people. After a bite from an infected mosquito, the parasite enters the person's bloodstream and travels to the liver where it grows and multiplies. During this time when the parasite is in the liver, there are no visible symptoms and the victim doesn't feel sick.
The parasite may stay in the liver for a period as short as 8 days or as long as several months to years. After it leaves the liver, it enters red blood cells and continues to grow and multiply. The red blood cells burst, freeing the parasites to attack other red blood cells. It is during this time that symptoms of malaria may begin to surface.
Convenient Dosing That Fits Easily Into Your Travel Plans
MALARONE provides easy, once-daily dosing and a shorter duration in treatment time, so you can concentrate on your trip, not your treatment.
MALARONE dosing begins only 2 days before departing for your trip.
Once-daily dosing while travelling makes it easy to fit MALARONE into your daily routine.
Only 1 more week of treatment is required when you get home so you get back to your normal routine faster than the 4 weeks required by other treatments.
Are you at Risk?
Many people believe that they have been vaccinated for malaria when in fact no such vaccination exists.
Malaria occurs in over 100 countries and territories. The World Health Organization estimates that approximately 40% of the global population is at risk for getting malaria.
Sometimes, one bite from an infected mosquito is all it takes to become infected and sick with malaria. Over 10,000 worldwide travelers fall ill with malaria after returning home from malaria-endemic areas.
Malaria can be fatal. Kidney failure, seizures, mental confusion, coma and possibly (even) death can occur if you are bitten by a malaria-infected mosquito and become sick with malaria.
The World Health Organization estimates that there are 300-500 million new cases of malaria each year, resulting in 1 million deaths.
Always take Malarone exactly as your doctor has told you.
Check with your doctor or pharmacist if you are not sure. Take Malarone with food or a milky drink, where possible. It is best to take Malarone at the same time each day.
To treat malaria
The usual dose for adults is 4 tablets once a day for 3 days.
Not for children, talk to your doctor. Not recommended for preventing malaria in children, or in adults who weigh less than 40 kgs.
To prevent malaria in adults:
start taking Malarone 1 to 2 days before travelling to an area which has malaria
continue taking it every day during your stay
continue taking it for another 7 days after your return to a malaria-free area.
For children the dose depends on their bodyweight:
11-20 kg – 1 tablet once a day for 3 days
21-30 kg – 2 tablets once a day for 3 days
31-40 kg – 3 tablets once a day for 3 days
over 40 kg – dose as for adults.
Not recommended for treating malaria in children who weigh less than 11 kgs. For children who weigh less than 11 kgs talk to your doctor. There may be a different type of Malarone tablet available in your country.
Special warnings and precautions for use
The safety and effectiveness of Malarone (atovaquone 250mg/proguanil hydrochloride 100mg tablets) for prophylaxis of malaria in patients who weigh less than 40kg has not been established.
Persons taking Malarone for prophylaxis or treatment of malaria should take a repeat dose if they vomit within 1 hour of dosing. In the event of diarrhoea, normal dosing should be continued. Absorption of atovaquone may be reduced in patients with diarrhoea or vomiting, but diarrhoea or vomiting was not associated with reduced efficacy in clinical trials of Malarone for malaria prophylaxis. However, as with other antimalarial agents, subjects with diarrhoea or vomiting should be advised to continue to comply with personal protection measures (repellants, bednets).
In patients with acute malaria who present with diarrhoea or vomiting, alternative therapy should be considered. If Malarone is used to treat malaria in these patients, parasitaemia should be closely monitored.
The safety and effectiveness of Malarone (atovaquone 250mg/proguanil hydrochloride 100mg tablets) for treatment of malaria in paediatric patients who weigh less than 11kg has not been established.
Malarone has not been evaluated for the treatment of cerebral malaria or other severe manifestations of complicated malaria including hyperparasitaemia, pulmonary oedema or renal failure.
Parasite relapse occurred commonly when P. vivax malaria was treated with Malarone alone. Travellers with intense exposure to P. vivax or P. ovale, and those who develop malaria caused by either of these parasites, will require additional treatment with a drug that is active against hypnozoites.
In the event of recrudescent infections due to P. falciparum after treatment with Malarone, or failure of chemoprophylaxis, patients should be treated with a different blood schizonticide.
Parasitaemia should be closely monitored in patients receiving concurrent metoclopramide or tetracycline (See Section 4.5).
The concomitant administration of Malarone and rifampicin or rifabutin is not recommended (See Section 4.5).
In patients with severe renal impairment (creatinine clearance < 30mL/min) alternatives to Malarone for treatment of acute P. falciparum malaria should be recommended whenever possible (See Sections 4.2, 4.3 and 5.2).
You should carefully read all product packaging and labels prior to use
Possible Side Effects from taking Malarone Tablets:
Dizziness has been reported. Patients should be warned that if affected they should not drive, operate machinery or take part in activities where this may put themselves or others at risk.
UK Mainland - Free Delievery To UK Mainland On All Orders Over £40 In Value.
Standard Delivery
For orders under £40 in value we charge £2.95 for UK mainland delivery, regardless of weight and
size. The vast majority of orders (over 90%) are despatched either on the same
working day or the following working day. A signature is required on receipt. Our standard delivery option includes packaging, handling, delivery insurance and Royal Mail 1st Class recorded delivery
postal costs.
Europe - Delievery Charge £7.49
Delivery to Europe is charged at £7.49 regardless of order value. Delivery is usually 3-6 days.
Americas & Rest Of The World - Delivery Charge £14.99
Delivery to regions outside of Europe are charged at £14.99 regardless of order value. Delivery is
usually 5-10 days. All prices shown online include VAT. At checkout VAT (
17.5 %) will be
deducted where applicable.
Note: Certain weight restrictions apply.